Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer

New England Journal of Medicine

Volumn 319, Issue 26, 1988, Pages 1681-1692

  Henderson, I C ^a   Mouridsen, H ^a   Abe, O ^a   Abeloff, M ^a   Ahmann, D ^a   Andersen, K ^a   Baum, M ^a   Bianco, A R ^a   Boccardo, F ^a   Bonadonna, G ^a   Buyse, M ^a   Buzdar, A ^a   Carbone, P ^a   Carpenter, J ^a   Chlebowski, R ^a   Collins, R ^a   Cooper, R ^a   Crowley, J ^a   Cuzick, J ^a   Day, N ^a   Delozier, T ^a   de Schryver, A ^a   Dubois, J ^a   Durrani, K ^a   Fisher, B ^a   Forbes, J ^a   Forrest, P ^a   Gelber, R ^a   Gelman, R ^a   Click, J ^a   Godwin, J ^a   Goldhirsch, A ^a   Gray, R ^a   Hayward, J ^a   Hill, C ^a   Howell, A ^a   Hubay, C ^a   Jakesz, R ^a   Kaufmann, M ^a   Kissin, M ^a   Larsson, L G ^a   Lippman, M ^a   Margreiter, R ^a   Mauriac, L ^a   McCardle, C ^a   Morrison, M ^a   Naja, A ^a   Nissen Meyer, R ^a   Nomura, Y ^a   Oates, G D ^a   Osborne, K ^a   Palshof, T ^a   Peek, U ^a   Peto, R ^a   Pritchard, K ^a   Redmond, C ^a   Repelaer van Driel, O ^a   Ribeiro, G ^a   Rubens, R ^a   Rutqvist, L ^a   Ryden, S ^a   Scanlon, E ^a   Scheurlen, H ^a   Semiglazov, V ^a   Senanayake, F ^a   Senn, H J ^a   Simon, R ^a   Smith, C ^a   Soderberg M ^a   Spittle, M ^a   Stewart, H ^a   Swindell, R ^a   Tormey, D ^a   Valagussa, P ^a   van Dongen, J ^a   Wallgren, A ^a   Wittes, R ^a   Wolmark, N ^a   Wood, W ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; ADULT; AGE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; EARLY CANCER; FATALITY; FEMALE; HUMAN; METHODOLOGY; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; META-ANALYSIS; MIDDLE AGED; RANDOM ALLOCATION; RECEPTORS, ESTROGEN; TAMOXIFEN;

EID: 0024269590     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198812293192601     Document Type: Article

References (7)

1. Adjuvant endocrine and cytotoxic therapy in early breast cancer: a systematic overview of all available randomized trials; first report of the Early Breast Cancer Trialists' Collaborative Group. Natl Cancer Inst Monogr (in press).
2. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335–71.
3. Collins R, Gray R, Godwin J, Peto R. Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Stat Med 1987; 6: 245–54.
4. Review of mortality results in randomised trials in early breast cancer. Lancet 1984; 2: 1205.
5. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1–39.
6. Peto R. Statistical aspects of cancer trials. In: Halnan K, ed. Treatment of cancer. London: Chapman & Hall, 1982:867–71.
7. Henderson IC. Adjuvant systemic therapy of early breast cancer and endocrine therapy of metastatic breast cancer. In: Harris JR, Hellman S, Henderson IC, Kinne DW, eds. Breast diseases. Philadelphia: J.B. Lippincott, 1987:324–53.